Palo Alto, Calif. — January 5, 2026 — Leads & Copy — BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced today that co-founder and CEO, Neil Kumar, Ph.D., will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 12 at 7:30 am PT.
To access the live webcast of BridgeBio’s investor webinar, visit the “Events & Presentations” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcast will be available on the BridgeBio website for 30 days following the event.
BridgeBio Pharma, Inc. (BridgeBio) is a biopharmaceutical company focused on discovering, creating, testing, and delivering medicines to treat patients who suffer from genetic diseases. Founded in 2015, BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. Its team of drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible.
BridgeBio Media Contact: Bubba Murarka, Executive Vice President contact@bridgebio.com (650)-789-8220
BridgeBio Investor Contact: Chinmay Shukla, Senior Vice President, Strategic Finance ir@bridgebio.com
Source: BridgeBio Pharma, Inc.
